ACHE and Alzheimer disease: During the early period (1971–2015), the focus was predominantly on acetylcholinesterase, acetylcholinesterase inhibitors, antioxidant activity, Alzheimer’s disease, dementia, oxidative stress, and related mechanisms, indicating a foundational exploration of neurochemical pathways and degenerative brain conditions.